Summary of the clinical studies reported in the 52nd Annual Scientific Sessions of the American College of Cardiology (Chicago USA, March 30- April 2, 2003);Resumen de los ensayos clínicos presentados en la 52 Sesión Científica Anual del American College of Cardiology (Chicago, EE. UU., 30 de marzo a 2 de abril de 2003)

Revista Espanola de Cardiologia

Volumn 56, Issue 6, 2003, Pages 601-606

  Bermejo, Javier ^a   Alfonso, Fernando ^a   Bosch, Xavier ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; FIBRINOGEN RECEPTOR ANTAGONIST; FOLIC ACID; HEPARIN; HYDROCHLOROTHIAZIDE; PACLITAXEL; PYRIDOXINE; RAPAMYCIN; SPIRONOLACTONE; THROMBIN INHIBITOR; TRANDOLAPRIL; TRANDOLAPRIL PLUS VERAPAMIL; VERAPAMIL; WARFARIN; XIMELAGATRAN;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL STUDY; CLINICAL TRIAL; CORONARY ARTERY RECANALIZATION; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SELECTIVITY; EPIDEMIOLOGICAL DATA; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART STIMULATION; HUMAN; HYPERTENSION; INCIDENCE; MEDICAL RESEARCH; MORTALITY; PRIMARY PREVENTION; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

EID: 0042810661     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13048158     Document Type: Article

References (2)

1. Pitt B, Remme W, Zannad F, Neaton J, Martínez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
2. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58.